+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID05123482

Phase IIIa Study of AZD8205 Alone or Combined With Anticancer Agents for Advanced Solid Tumors

Led by AstraZeneca · Updated on 2026-10-13

460

Participants Needed

67

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating AZD8205, a new antibody drug conjugate, as a possible treatment for advanced or metastatic solid tumors including breast cancer, biliary tract carcinoma, ovarian cancer, endometrial cancer, and squamous non-small cell lung cancer. This Phase IIIa multi-center, open-label study aims to assess AZD8205 alone or combined with other anti-cancer agents to determine safety, tolerability, dosing, and anti-tumor activity. The study includes multiple sub-studies focusing on different drug combinations and tumor types. Participants may receive AZD8205 as monotherapy or in combination with rilvegostomig, saruparib, and AZD9574. The study has dose escalation phases to identify the recommended phase 2 dose and expansion phases to evaluate anti-tumor effects in selected solid tumors. Some combinations may involve triplet therapies depending on emerging safety data. Treatments will be given according to protocol schedules within each sub-study. Throughout the study, participants will undergo regular monitoring for adverse events, lab tests, ECGs, vital signs, and pharmacokinetic assessments for up to two years. Researchers will measure outcomes such as response rates, duration of response, progression-free survival, overall survival, and immunogenicity. Safety evaluations continue from informed consent to 30 days after the last dose. The study is randomized and open-label, with ongoing assessments during treatment and follow-up periods.

CONDITIONS

Brief Title

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Team

A

AstraZeneca Clinical Study Information Center

A

AstraZeneca Breast Cancer Study Locator Service

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here